192 related articles for article (PubMed ID: 31578284)
1. JARID2 and the PRC2 complex regulate the cell cycle in skeletal muscle.
Adhikari A; Mainali P; Davie JK
J Biol Chem; 2019 Dec; 294(51):19451-19464. PubMed ID: 31578284
[TBL] [Abstract][Full Text] [Related]
2. The PRC2 complex directly regulates the cell cycle and controls proliferation in skeletal muscle.
Adhikari A; Davie JK
Cell Cycle; 2020 Sep; 19(18):2373-2394. PubMed ID: 32816597
[TBL] [Abstract][Full Text] [Related]
3. JARID2 and the PRC2 complex regulate skeletal muscle differentiation through regulation of canonical Wnt signaling.
Adhikari A; Davie J
Epigenetics Chromatin; 2018 Aug; 11(1):46. PubMed ID: 30119689
[TBL] [Abstract][Full Text] [Related]
4. Nucleosome-binding activities within JARID2 and EZH1 regulate the function of PRC2 on chromatin.
Son J; Shen SS; Margueron R; Reinberg D
Genes Dev; 2013 Dec; 27(24):2663-77. PubMed ID: 24352422
[TBL] [Abstract][Full Text] [Related]
5. Interferon-γ resets muscle cell fate by stimulating the sequential recruitment of JARID2 and PRC2 to promoters to repress myogenesis.
Londhe P; Davie JK
Sci Signal; 2013 Dec; 6(305):ra107. PubMed ID: 24327761
[TBL] [Abstract][Full Text] [Related]
6. Jarid2 Methylation via the PRC2 Complex Regulates H3K27me3 Deposition during Cell Differentiation.
Sanulli S; Justin N; Teissandier A; Ancelin K; Portoso M; Caron M; Michaud A; Lombard B; da Rocha ST; Offer J; Loew D; Servant N; Wassef M; Burlina F; Gamblin SJ; Heard E; Margueron R
Mol Cell; 2015 Mar; 57(5):769-783. PubMed ID: 25620564
[TBL] [Abstract][Full Text] [Related]
7. Distinct PRC2 subunits regulate maintenance and establishment of Polycomb repression during differentiation.
Petracovici A; Bonasio R
Mol Cell; 2021 Jun; 81(12):2625-2639.e5. PubMed ID: 33887196
[TBL] [Abstract][Full Text] [Related]
8. Jarid2 and PRC2, partners in regulating gene expression.
Li G; Margueron R; Ku M; Chambon P; Bernstein BE; Reinberg D
Genes Dev; 2010 Feb; 24(4):368-80. PubMed ID: 20123894
[TBL] [Abstract][Full Text] [Related]
9. Polycomb recruitment at the Class II transactivator gene.
Boyd NH; Morgan JE; Greer SF
Mol Immunol; 2015 Oct; 67(2 Pt B):482-91. PubMed ID: 26283540
[TBL] [Abstract][Full Text] [Related]
10. Protein arginine methyltransferase 5 (PRMT5) inhibition induces lymphoma cell death through reactivation of the retinoblastoma tumor suppressor pathway and polycomb repressor complex 2 (PRC2) silencing.
Chung J; Karkhanis V; Tae S; Yan F; Smith P; Ayers LW; Agostinelli C; Pileri S; Denis GV; Baiocchi RA; Sif S
J Biol Chem; 2013 Dec; 288(49):35534-47. PubMed ID: 24189068
[TBL] [Abstract][Full Text] [Related]
11. A novel form of JARID2 is required for differentiation in lineage-committed cells.
Al-Raawi D; Jones R; Wijesinghe S; Halsall J; Petric M; Roberts S; Hotchin NA; Kanhere A
EMBO J; 2019 Feb; 38(3):. PubMed ID: 30573669
[TBL] [Abstract][Full Text] [Related]
12. Jarid2 binds mono-ubiquitylated H2A lysine 119 to mediate crosstalk between Polycomb complexes PRC1 and PRC2.
Cooper S; Grijzenhout A; Underwood E; Ancelin K; Zhang T; Nesterova TB; Anil-Kirmizitas B; Bassett A; Kooistra SM; Agger K; Helin K; Heard E; Brockdorff N
Nat Commun; 2016 Nov; 7():13661. PubMed ID: 27892467
[TBL] [Abstract][Full Text] [Related]
13. EZH2 variants differentially regulate polycomb repressive complex 2 in histone methylation and cell differentiation.
Mu W; Starmer J; Yee D; Magnuson T
Epigenetics Chromatin; 2018 Dec; 11(1):71. PubMed ID: 30522506
[TBL] [Abstract][Full Text] [Related]
14. PRC2.1 and PRC2.2 Synergize to Coordinate H3K27 Trimethylation.
Healy E; Mucha M; Glancy E; Fitzpatrick DJ; Conway E; Neikes HK; Monger C; Van Mierlo G; Baltissen MP; Koseki Y; Vermeulen M; Koseki H; Bracken AP
Mol Cell; 2019 Nov; 76(3):437-452.e6. PubMed ID: 31521505
[TBL] [Abstract][Full Text] [Related]
15. Polycomb Repressive Complex 2 Methylates Elongin A to Regulate Transcription.
Ardehali MB; Anselmo A; Cochrane JC; Kundu S; Sadreyev RI; Kingston RE
Mol Cell; 2017 Dec; 68(5):872-884.e6. PubMed ID: 29153392
[TBL] [Abstract][Full Text] [Related]
16. PRC2 complexes with JARID2, MTF2, and esPRC2p48 in ES cells to modulate ES cell pluripotency and somatic cell reprogramming.
Zhang Z; Jones A; Sun CW; Li C; Chang CW; Joo HY; Dai Q; Mysliwiec MR; Wu LC; Guo Y; Yang W; Liu K; Pawlik KM; Erdjument-Bromage H; Tempst P; Lee Y; Min J; Townes TM; Wang H
Stem Cells; 2011 Feb; 29(2):229-40. PubMed ID: 21732481
[TBL] [Abstract][Full Text] [Related]
17. Retinoblastoma tumor suppressor protein-dependent methylation of histone H3 lysine 27 is associated with irreversible cell cycle exit.
Blais A; van Oevelen CJ; Margueron R; Acosta-Alvear D; Dynlacht BD
J Cell Biol; 2007 Dec; 179(7):1399-412. PubMed ID: 18166651
[TBL] [Abstract][Full Text] [Related]
18. Nucleation and Propagation of Heterochromatin by the Histone Methyltransferase PRC2: Geometric Constraints and Impact of the Regulatory Subunit JARID2.
Ge EJ; Jani KS; Diehl KL; Müller MM; Muir TW
J Am Chem Soc; 2019 Sep; 141(38):15029-15039. PubMed ID: 31479253
[TBL] [Abstract][Full Text] [Related]
19. Jarid2/Jumonji coordinates control of PRC2 enzymatic activity and target gene occupancy in pluripotent cells.
Peng JC; Valouev A; Swigut T; Zhang J; Zhao Y; Sidow A; Wysocka J
Cell; 2009 Dec; 139(7):1290-302. PubMed ID: 20064375
[TBL] [Abstract][Full Text] [Related]
20. Interactions between JARID2 and noncoding RNAs regulate PRC2 recruitment to chromatin.
Kaneko S; Bonasio R; Saldaña-Meyer R; Yoshida T; Son J; Nishino K; Umezawa A; Reinberg D
Mol Cell; 2014 Jan; 53(2):290-300. PubMed ID: 24374312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
